Why is the ICMR revising the National Essential Diagnostics List

The Indian Council of Medical Research (ICMR) has decided to revise the National Essential Diagnostics List (NEDL) for the following reasons: 1. Updated Diagnostic Technologies: The field of diagnostics has seen significant advancements since 2019, with the introduction of new tests and technologies. The revision aims to incorporate these advancements and ensure the inclusion of the most essential and effective diagnostic tests. 2. Improved Disease Detection and Management: The NEDL plays a crucial role in guiding healthcare professionals in diagnosing and managing various diseases. By updating the list, the ICMR aims to enhance disease detection, management, and treatment outcomes. 3. Public Health Priorities: The revision will align the NEDL with the current public health priorities in the country. The inclusion of diagnostic tests for emerging infectious diseases, non-communicable diseases, and specific health conditions can help address the pressing healthcare needs of the population. 4. Accessibility and Affordability: The ICMR aims to ensure that essential diagnostic tests are accessible and affordable to all sections of society. The revision will include tests that are cost-effective, have wide availability, and are of high-quality, promoting equitable healthcare access. 5. International Best Practices: The ICMR is likely to consider international guidelines and best practices while revising the NEDL. This will enable India to align its diagnostic strategies with global standards, ensuring quality and reliability. Overall, the revision of the NEDL by the ICMR aims to improve disease diagnosis, enhance public health outcomes, and ensure equitable access to essential diagnostic tests in India.